检索结果 - J. Capdevila

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    1653P Cabozantinib (C) vs placebo (P) in patients (pts) with radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC) who progressed after prior VEGFR-targeted therapy: Outcomes by duration of prior lenvatinib (L) treatment

    1653P Cabozantinib (C) vs placebo (P) in patients (pts) with radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC) who progressed after prior VEGFR-targeted therapy: Ou... 由 M.S. Brose, J.A. Krajewska, F. Vaisman, A.O. Hoff, E. Hitre, J. Oliver, D.S. Williamson, N. Berry, J. Capdevila Castillón

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    LBA67 Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who have progressed after prior VEGFR-targeted therapy: Updated results from the phase III COSMIC-311 trial and prespecified subgroup analyses by prior therapy

    LBA67 Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who have progressed after prior VEGFR-targeted therapy: Updated results from... 由 J. Capdevila, Bruce Robinson, Steven I. Sherman, Barbara Jarząb, C-C. Lin, Fernanda Vaisman, Ana O. Hoff, Erika Hitre, Daniel W. Bowles, Seema Sen, Priyanka Patel, Jennifer Oliver, Bhumsuk Keam, Marcia S. Brose

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    1927TiP LIBRETTO-531: Selpercatinib in patients with treatment (Tx)-naïve RET-mutant medullary thyroid cancer (MTC)

    1927TiP LIBRETTO-531: Selpercatinib in patients with treatment (Tx)-naïve RET-mutant medullary thyroid cancer (MTC) 由 Jorge Hernando, Valentina Tarasova, Mimi I. Hu, Eric J. Sherman, Marcia S. Brose, Bruce Robinson, Makoto Tahara, Lori J. Wirth, Andreas Sashegyi, Victoria Soldatenkova, Bo Lin, Jennifer Wright, Ana O. Hoff, Sophie Leboulleux, Rossella Elisei, J. Capdevila

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Treatment of Advanced BP-NETS with Lanreotide Autogel/Depot vs Placebo: the Phase III SPINET Study

    Treatment of Advanced BP-NETS with Lanreotide Autogel/Depot vs Placebo: the Phase III SPINET Study 由 Éric Baudin, J. Capdevila, Dieter Hörsch, Simron Singh, M. Caplin, Edward M. Wolin, Wieneke A. Buikhuisen, Markus Raderer, Éric Dansin, Christian Grohé, Diego Ferone, A Houchard, X.-M. Truong-Thanh, Diane Reidy‐Lagunes, NULL AUTHOR_ID

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Early evolutionary divergence between papillary and anaplastic thyroid cancers

    Early evolutionary divergence between papillary and anaplastic thyroid cancers 由 J. Capdevila, Regina Mayor, Francesco M. Mancuso, Carmela Iglesias, Ginevra Caratù, Ignacio Matos, Carles Zafón, Jorge Hernando, A. Petit, Paolo Nucíforo, José Cameselle‐Teijeiro, Clara V. Álvarez, Juan A. Recio, Josep Tabernero, Xavier Matías‐Guiu, Ana Vivancos, Joan Seoane

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: